Benchstable product family

High-quality GMP-compliant products

As a leader in quality, innovation, and capacity, we are dedicated to operational excellence in everything we do—from how we manage our core quality processes to our facility investments and our risk management systems. Gibco media products are manufactured according to good manufacturing practices (GMP) to help ensure product performance.


Quality comes first and the proof is in our performance

gibco media icon

Manufacturing Gibco media and reagents since 1962

bottle icon

Supplying the top 50 biopharmaceutical companies worldwide with solutions that drive success

document icons

Over 200,000 publication references and counting


We have been delivering GMP-compliant media for over 30 years

  • Our manufacturing sites are ISO 13485–certified
  • FDA-registered and manufacture in conformity with GMP for medical devices, 21 CFR Part 820. 

Key benefits:

Ensures the consistency, reliability, and high quality of our Gibco cell culture reagents.


Our global GMP manufacturing capabilities

Delivering continuity of supply with the highest-quality products to all of our customers globally.

Our registered ISO-certified and state-of-the-art facilities are strategically located around the world to support our customers.

map of cGMP facilities around the world

Quality and safety

The focus on quality and consistency enables us to help our customers achieve their goals.

Commitment to quality

We are committed to your success. By maintaining a standard of unassailable quality and continuous process improvement, our quality management systems and policies are designed to meet your ever-changing needs. We know how critical product quality is to your success, which is why we are committed to thorough documentation, design control, and extensive QC testing.

Quality management systems

Our stringent management controls, process controls, and built-in process improvement steps ensure we meet the quality standards that you expect. We aim to meet quality and regulatory standards and to exceed customer expectations in all that we do. At Thermo Fisher Scientific, we welcome customer and supplier audits as a way to ensure our quality standards meet the expectations and ever-changing needs of our customers.

Quality control testing–validated processes and test methods

Gibco Cell Therapy Systems (CTS)

All of our CTS products meet the minimum quality control requirements as outlined in USP <1043> (ancillary materials for cell, gene, and tissue-engineered products) and Ph. EUR 5.2.12 (raw materials of biological origin for the production of cell-based and gene therapy medicinal products).

Gibco Cell Therapy Systems (CTS) media and reagents undergo extensive QC testing following pharmacopeia test methods where possible. Our routine QC on all CTS reagents includes:

  • Sterility (for aseptic products only) or Bioburden Testing
  • Mycoplasma
  • Performance testing based on the intended use
  • Real time stability with meaningful stability indicating tests

Our biological origin raw material traceability, quality control testing and test method references are detailed on our Certificates of Analysis and Origin. These documents are designed to enable risk assessment of CTS products for use in clinical manufacturing. All CTS products have SDS available.

Commitment to quality

We are committed to your success. By maintaining a standard of unassailable quality and continuous process improvement, our quality management systems and policies are designed to meet your ever-changing needs. We know how critical product quality is to your success, which is why we are committed to thorough documentation, design control, and extensive QC testing.

Quality management systems

Our stringent management controls, process controls, and built-in process improvement steps ensure we meet the quality standards that you expect. We aim to meet quality and regulatory standards and to exceed customer expectations in all that we do. At Thermo Fisher Scientific, we welcome customer and supplier audits as a way to ensure our quality standards meet the expectations and ever-changing needs of our customers.

Quality control testing–validated processes and test methods

Gibco Cell Therapy Systems (CTS)

All of our CTS products meet the minimum quality control requirements as outlined in USP <1043> (ancillary materials for cell, gene, and tissue-engineered products) and Ph. EUR 5.2.12 (raw materials of biological origin for the production of cell-based and gene therapy medicinal products).

Gibco Cell Therapy Systems (CTS) media and reagents undergo extensive QC testing following pharmacopeia test methods where possible. Our routine QC on all CTS reagents includes:

  • Sterility (for aseptic products only) or Bioburden Testing
  • Mycoplasma
  • Performance testing based on the intended use
  • Real time stability with meaningful stability indicating tests

Our biological origin raw material traceability, quality control testing and test method references are detailed on our Certificates of Analysis and Origin. These documents are designed to enable risk assessment of CTS products for use in clinical manufacturing. All CTS products have SDS available.

Scaling up

Streamline the path from discovery to cure. Discover cell therapy solutions for every step.

Learn more about cell therapy systems products

Resources

Support

  • Cell Culture Support Center
    Find technical support recommendations for your cell culture workflows, including tips for experimental setup and in-depth troubleshooting help.
  • Need technical support?
    Contact our expert team for technical and application support of Laboratory Products.
Intended use of the products mentioned on this page vary. For specific intended use statements please refer to the product label.